Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Healthcare Resource Utilization with Rasburicase in the Management of Patients with Tumor Lysis in the Outpatient Setting: Results from a Community Oncology Cohort

Ali McBride, PharmD,MS, Melissa Hagan, PhD, Mei Xue, MBA, Robert E Smith, MD

Blood (2019) 134 (Supplement_1): 3401.

https://doi.org/10.1182/blood-2019-125922

Published: 2019

Journal Articles

The Impact of Diagnosis to Treatment Interval on the Outcome of Patients with Acute Myeloid Leukemia

Samah Nassereddine, MD, Kimberley Doucette, MD MSc, Vanya Aggarwal, Richard Amdur, PhD, Imad A. Tabbara, MD, Catherine E. Lai, MD

Blood (2019) 134 (Supplement_1): 2212.

https://doi.org/10.1182/blood-2019-124150

Published: 2019

Journal Articles

Prognostic Impact of Time from Diagnosis to Initial Chemotherapy for Acute Myeloid Leukemia

Yoshimasa Kamoda, MD, Akira Hangaishi, MD PhD, Hiroki Hayashida, MD, Yusuke Uchibori, MD, Hiromitsu Iizuka, MD PhD, Michiko Kida, MD PhD, Kensuke Usuki, MD PhD

Blood (2018) 132 (Supplement 1): 3981.

https://doi.org/10.1182/blood-2018-99-111123

Published: 2018

Journal Articles

Comparative Effectiveness of Rasburicase and Allopurinol in Children with Acute Lymphoblastic Leukemia: An Emulated Pragmatic Trial Using Observational Data

Regina M Myers, MD, Kelly D Getz, PhD, Yimei Li, PhD, Yuan-Shung V. Huang, MS, Rebecca Citrin, MD, Caitlin W Elgarten, MD, Benjamin L Laskin, MD, Joseph P. Horowitz, Brian T. Fisher, DO, Richard Aplenc, MD PhD

Blood (2018) 132 (Supplement 1): 830.

https://doi.org/10.1182/blood-2018-99-114883

Published: 2018

Journal Articles

Acute Promyelocytic Leukemia: Clinical Outcomes, Induction Deaths and Challenges

Tara Rajendran, MBBS, Krishna Prasad, MBBS, MD(MDcine), DM (Oncology)

Blood (2018) 132 (Supplement 1): 5191.

https://doi.org/10.1182/blood-2018-99-116705

Published: 2018

Journal Articles

Cost of Hospitalization in Patients with Cancer and Febrile Neutropenia and Impact of Comorbid Conditions

Gary H. Lyman, MD MPH, Marek S. Poniewierski, MD MS, Jeffrey Crawford, MD, David C. Dale, MD, Eva Culakova, PhD MS

Blood (2015) 126 (23): 2089.

https://doi.org/10.1182/blood.V126.23.2089.2089

Published: 2015

Journal Articles

A Statistical Model for Predicting Neutropenic Fever

Ariel Nelson, MD, Dan Eastwood, MS, Tao Wang, PhD, Karen Carlson, MD PhD, Laura C Michaelis, MD, Marcelo C. Pasquini, MD MS, Parameswaran N. Hari, MD, Christopher R. Chitambar, MD, Timothy S. Fenske, MD, Mary Beth Graham, MD, Mehdi Hamadani, MD, Anita D'Souza, MBBS, MD, Ehab Atallah, MD

Blood (2014) 124 (21): 5258.

https://doi.org/10.1182/blood.V124.21.5258.5258

Published: 2014

Journal Articles

Flow Cytometry and Cytogenetics of Fine Needle Aspiration Biopsy Samples Is a Reliable Method for Diagnosing Burkitt Lymphoma. Evaluation of 78 Cases from a Single-Institution

Rymkiewicz Grzegorz, MD PhD, Katarzyna Blachnio, MS, Beata Grygalewicz, PhD, Zbigniew Bystydzienski, PhD, Renata Woroniecka, PhD, Beata Sledz-Gawronska, MS, Joanna Romejko-Jarosinska, MD PhD, Katarzyna Domanska-Czyz, MD, Michalina Zajdel, MS, Kinga Sikorska-Mali, MD, Jan Konrad Siwicki, PhD, Barbara Pienkowska-Grela, PhD, Monika Prochorec-Sobieszek, MD PhD, Jan Walewski, MD PhD

Blood (2014) 124 (21): 1640.

https://doi.org/10.1182/blood.V124.21.1640.1640

Published: 2014

Journal Articles

The VIP (Very Immunocompromised Patient) Protocol: Improved Access To Care and Time To Antibiotics

Paul J. Shaughnessy, MD, Ann Kelley, RN, Roberta Tremper, RN, Jonathan Tinker, Carlos Bachier, MD, Joseph Holahan, MD, Roger M. Lyons, MD, Charles F. LeMaistre, MD

Blood (2013) 122 (21): 2978.

https://doi.org/10.1182/blood.V122.21.2978.2978

Published: 2013

Journal Articles

Prospective Study Of An Emergency Department Febrile Neutropenia Pathway In Patients With Hematologic Malignancies

Michael K. Keng, MD, Elaine Thallner, MD, MS, Paul Elson, ScD, Christine Zayac, MA, Jennifer Sekeres, PharmD, BCPS, Candice M. Wenzell, PharmD, BCOP, Erika M. Gallagher, PharmD, BCOP, Catherine M. Weber, PharmD, BCOP, Marc A. Earl, PharmD, BCOP, Sudipto Mukherjee, MD, PhD, MPH, David J. Seastone, DO, PhD, Brad Pohlman, MD, Eric Cober, MD, Beth Rodgers, RN, MSN, CEN, Virginia B. Foster, PhD, MPH, Joy Yuhas, RN, MSN, Matt Kalaycio, MD, Brian J. Bolwell, MD, Mikkael A. Sekeres, MD, MS

Blood (2013) 122 (21): 556.

https://doi.org/10.1182/blood.V122.21.556.556

Published: 2013

Journal Articles

Costs and Outcomes Associated with Rasburicase Versus Allopurinol in Patients with Tumor Lysis Syndrome.

Mitchell S. Cairo, MD, Stephen Thompson, MS, Krishna Tangirala, MPH, Michael T. Eaddy, PharmD, PhD

Blood (2012) 120 (21): 3175.

https://doi.org/10.1182/blood.V120.21.3175.3175

Published: 2012

Journal Articles

Time Elapsed From AML Diagnosis to Induction Chemotherapy Affects Overall Survival

Luis Arthur F. Pelloso, MD, PhD, Sandra Serson Rohr, MD, Mihoko Yamamoto, MD, PhD, Maria de Lourdes L. F. Chauffaille, MD, PhD

Blood (2011) 118 (21): 4262.

https://doi.org/10.1182/blood.V118.21.4262.4262

Published: 2011

Journal Articles

Single 4.5mg Dose of Rasburicase for Tumor Lysis Syndrome In Adults

Barbara Yim, PharmD, BCOP, Anne Navaleza, PharmD, Augustin Haidau, MD, Shylendra Sreenivasappa, MD, MPH, Mohammed A. Kassem, MD, Bety C. Ciobanu, MD, Tareq Braik, MD, Manila Gaddh, MD, Paul G. Rubinstein, MD, Moushmi Shah, MD, Margaret Telfer, MD, Rose Catchatourian, MD

Blood (2010) 116 (21): 1779.

https://doi.org/10.1182/blood.V116.21.1779.1779

Published: 2010

Journal Articles

Chemotherapy Induced Neutropenic Fever Seen at Emergency Room: A Review of 102 Cases.

Joo Han Lim, Hyeon Gyu Yi, Moon Hee Lee, Hoon Kim, Chul Soo Kim

Blood (2009) 114 (22): 4530.

https://doi.org/10.1182/blood.V114.22.4530.4530

Published: 2009

Journal Articles

Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients

Mikkael A. Sekeres, Paul Elson, Matt E. Kalaycio, Anjali S. Advani, Edward A. Copelan, Stefan Faderl, Hagop M. Kantarjian, Elihu Estey

Blood (2009) 113 (1): 28–36.

https://doi.org/10.1182/blood-2008-05-157065

Published: 2009

NARROW

Healthcare Resource Utilization with Rasburicase in the Management of Patients with Tumor Lysis in the Outpatient Setting: Results from a Community Oncology Cohort

The Impact of Diagnosis to Treatment Interval on the Outcome of Patients with Acute Myeloid Leukemia

Prognostic Impact of Time from Diagnosis to Initial Chemotherapy for Acute Myeloid Leukemia

Comparative Effectiveness of Rasburicase and Allopurinol in Children with Acute Lymphoblastic Leukemia: An Emulated Pragmatic Trial Using Observational Data

Acute Promyelocytic Leukemia: Clinical Outcomes, Induction Deaths and Challenges

Cost of Hospitalization in Patients with Cancer and Febrile Neutropenia and Impact of Comorbid Conditions

A Statistical Model for Predicting Neutropenic Fever

Flow Cytometry and Cytogenetics of Fine Needle Aspiration Biopsy Samples Is a Reliable Method for Diagnosing Burkitt Lymphoma. Evaluation of 78 Cases from a Single-Institution

The VIP (Very Immunocompromised Patient) Protocol: Improved Access To Care and Time To Antibiotics

Prospective Study Of An Emergency Department Febrile Neutropenia Pathway In Patients With Hematologic Malignancies

Costs and Outcomes Associated with Rasburicase Versus Allopurinol in Patients with Tumor Lysis Syndrome.

Time Elapsed From AML Diagnosis to Induction Chemotherapy Affects Overall Survival

Single 4.5mg Dose of Rasburicase for Tumor Lysis Syndrome In Adults

Chemotherapy Induced Neutropenic Fever Seen at Emergency Room: A Review of 102 Cases.

Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only